LncRNA GSTM3TV2 Promotes Cell Proliferation and Invasion via miR-597/FOSL2 Axis in Hepatocellular Carcinoma

被引:5
|
作者
Hu, Yuting [1 ]
Qiu, Wei [2 ]
Kong, Zhijun [1 ]
Wu, Siyuan [1 ]
Liu, Yi [1 ]
Zhu, Chunfu [1 ]
Qin, Xihu [1 ]
机构
[1] Nanjing Med Univ, Dept Hepatobiliary Surg, Affiliated Changzhou 2 Peoples Hosp, Changzhou 213003, Jiangsu, Peoples R China
[2] First Hosp Hanbin Dist, Dept Hepatobiliary & Pancreat Surg, Ankang 725000, Shanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
LONG NONCODING RNA; CANCER;
D O I
10.1155/2021/3445970
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mounting evidence has recently shown that role of long noncoding RNA is critical in many human cancers. lncRNA GSTM3TV2 was first proven to play a vital role in pancreatic cancer. However, the mechanism of lncRNA GSTM3TV2 in hepatocellular carcinoma (HCC) is still uncovered. Here, we object to distinguish the expression of lncRNA GSTM3TV2 and reveal its mechanistic relationship with HCC. We observed that the expression of lncRNA GSTM3TV2 and FOSL2 were upregulated in HCC. Knockdown of lncRNA GSTM3TV2 significantly inhibited cell proliferation. Meanwhile, the migration and invasion of HCC cells were greatly decreased by the downregulated lncRNA GSTM3TV2. The luciferase reporter assays showed that lncRNA GSTM3TV2 could be directly bound to miR-597, and the level of miR-597 was also decreased in the tumor tissues. lncRNA GSTM3TV2 could stabilize FOSL2 expression, resulting in the oncogenic properties of lncRNA GSTM3TV2 in HCC. Our study indicated the oncogenic activities of lncRNA GSTM3TV2 and emphasized the role of the miR-597/FOSL2 signaling pathway.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2
    He, Jiangtu
    Mai, Jieying
    Li, Yan
    Chen, Linyi
    Xu, Hui
    Zhu, Xiaofei
    Pan, Qiuhui
    ONCOLOGY REPORTS, 2017, 37 (05) : 2672 - 2678
  • [2] Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis
    Ji, Chenggang
    Hong, Xiaocheng
    Lan, Bo
    Lin, Ye
    He, Yingxin
    Chen, Jiayang
    Liu, Xi
    Ye, Weijie
    Mo, Zhikang
    She, Zhanpeng
    Lin, Shuwen
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (09) : 3074 - 3085
  • [3] Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis
    Chenggang Ji
    Xiaocheng Hong
    Bo Lan
    Ye Lin
    Yingxin He
    Jiayang Chen
    Xi Liu
    Weijie Ye
    Zhikang Mo
    Zhanpeng She
    Shuwen Lin
    Digestive Diseases and Sciences, 2021, 66 : 3074 - 3085
  • [4] miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2
    Sun, Xiangran
    Dai, Guo
    Yu, Ling
    Hu, Qingzhu
    Chen, Jingteng
    Guo, Weichun
    SCIENTIFIC REPORTS, 2018, 8
  • [5] miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2
    Xiangran Sun
    Guo Dai
    Ling Yu
    Qingzhu Hu
    Jingteng Chen
    Weichun Guo
    Scientific Reports, 8
  • [6] The IGF2BP2-lncRNA TRPC7-AS1 axis promotes hepatocellular carcinoma cell proliferation and invasion
    Zhang, Xu
    Li, Zilin
    Nie, Huizong
    Huang, Yue
    Du, Jingyang
    Xi, Yiling
    Guo, Chaoqin
    Mu, Mingshan
    Li, Xiangyu
    Zheng, Xiaoliang
    Xu, Qiuran
    Huang, Dongsheng
    Tu, Linglan
    Cheng, Liyan
    CELLULAR SIGNALLING, 2024, 117
  • [7] MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2)
    Li, Shuo
    Liu, Zhuo
    Fang, Xue-dong
    Wang, Xiu-ying
    Fei, Bing-yuan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [8] LncRNA TUG1 Promotes Hepatocellular Carcinoma Migration and Invasion Via Targeting miR-137/AKT2 Axis
    Li, Wei
    Ge, Jinzhao
    Xie, Jinju
    Yang, Jidong
    Chen, Jin'e
    He, Tao
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2021, 36 (10) : 850 - 862
  • [9] Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR-4429/UBE2C axis
    Chen, Zhiping
    Zhang, Mengting
    Lu, Yukang
    Ding, Tao
    Liu, Zhanyu
    Liu, Yanmei
    Zhou, Zhaoling
    Wang, Lanfeng
    ONCOLOGY REPORTS, 2022, 48 (03)
  • [10] LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis
    Chen, Huiyong
    Wang, Linhui
    Liu, Jingting
    Wan, Zihao
    Zhou, Lin
    Liao, Hongliang
    Wan, Renping
    CANCER BIOLOGY & THERAPY, 2023, 24 (01)